Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Zona Glomerulosa | 5 | 2019 | 6 | 1.36 | Why? |
| Immunization | 12 | 2021 | 2019 | 1.19 | Why? |
| Advisory Committees | 19 | 2021 | 1418 | 1.04 | Why? |
| Sodium, Dietary | 3 | 2017 | 45 | 0.86 | Why? |
| Caloric Restriction | 2 | 2018 | 56 | 0.86 | Why? |
| Mycoplasma hominis | 1 | 2017 | 15 | 0.72 | Why? |
| Magnesium | 1 | 2021 | 290 | 0.71 | Why? |
| Diet, Sodium-Restricted | 1 | 2017 | 23 | 0.71 | Why? |
| Lacerations | 1 | 2017 | 35 | 0.68 | Why? |
| Mycoplasma Infections | 1 | 2017 | 65 | 0.67 | Why? |
| Aldosterone | 4 | 2019 | 155 | 0.65 | Why? |
| Vertigo | 1 | 2017 | 141 | 0.63 | Why? |
| Cerebellum | 1 | 2017 | 119 | 0.62 | Why? |
| Cerebral Small Vessel Diseases | 1 | 2017 | 89 | 0.62 | Why? |
| United States Food and Drug Administration | 4 | 2021 | 1276 | 0.59 | Why? |
| Dizziness | 1 | 2017 | 275 | 0.57 | Why? |
| Vagina | 1 | 2017 | 327 | 0.56 | Why? |
| Blood Pressure | 5 | 2019 | 2198 | 0.50 | Why? |
| Immunization Schedule | 6 | 2020 | 1305 | 0.50 | Why? |
| Cerebral Hemorrhage | 2 | 2018 | 820 | 0.48 | Why? |
| Angiotensin II | 1 | 2018 | 601 | 0.47 | Why? |
| Kidney | 2 | 2021 | 3648 | 0.38 | Why? |
| Rats, Wistar | 4 | 2018 | 621 | 0.38 | Why? |
| Hepatitis A Vaccines | 2 | 2019 | 52 | 0.37 | Why? |
| Stroke | 5 | 2018 | 8839 | 0.36 | Why? |
| Hepatitis A | 2 | 2019 | 140 | 0.32 | Why? |
| Practice Guidelines as Topic | 10 | 2021 | 15421 | 0.32 | Why? |
| Renin-Angiotensin System | 3 | 2018 | 3661 | 0.31 | Why? |
| Magnetic Resonance Imaging | 3 | 2018 | 6551 | 0.31 | Why? |
| Pneumococcal Vaccines | 3 | 2018 | 571 | 0.26 | Why? |
| Sodium Chloride, Dietary | 3 | 2019 | 62 | 0.26 | Why? |
| Renin | 3 | 2017 | 167 | 0.26 | Why? |
| Insulin Resistance | 3 | 2018 | 669 | 0.26 | Why? |
| Drug Approval | 6 | 2021 | 1325 | 0.25 | Why? |
| Pneumococcal Infections | 3 | 2018 | 562 | 0.25 | Why? |
| Calmodulin-Binding Proteins | 2 | 2017 | 6 | 0.25 | Why? |
| Health Care Rationing | 4 | 2021 | 2558 | 0.24 | Why? |
| Hypertension | 4 | 2018 | 8895 | 0.24 | Why? |
| Viral Vaccines | 2 | 2020 | 7560 | 0.23 | Why? |
| Adverse Drug Reaction Reporting Systems | 6 | 2021 | 694 | 0.23 | Why? |
| Health Policy | 1 | 2020 | 6242 | 0.20 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2021 | 6166 | 0.20 | Why? |
| Vaccines | 4 | 2020 | 3692 | 0.19 | Why? |
| Histone Demethylases | 1 | 2019 | 31 | 0.19 | Why? |
| United States | 22 | 2021 | 46150 | 0.19 | Why? |
| Serogroup | 2 | 2018 | 510 | 0.19 | Why? |
| Animal Nutritional Physiological Phenomena | 1 | 2017 | 8 | 0.18 | Why? |
| Product Surveillance, Postmarketing | 1 | 2020 | 189 | 0.18 | Why? |
| Streptococcus pneumoniae | 3 | 2018 | 827 | 0.18 | Why? |
| Nicotinamide Phosphoribosyltransferase | 1 | 2017 | 30 | 0.18 | Why? |
| Caveolin 1 | 1 | 2018 | 73 | 0.18 | Why? |
| Endothelin-1 | 1 | 2017 | 69 | 0.18 | Why? |
| Zanamivir | 1 | 2017 | 63 | 0.18 | Why? |
| Zona Reticularis | 1 | 2017 | 10 | 0.17 | Why? |
| Receptors, Mineralocorticoid | 1 | 2017 | 15 | 0.17 | Why? |
| Nystagmus, Pathologic | 1 | 2017 | 30 | 0.17 | Why? |
| Public-Private Sector Partnerships | 1 | 2020 | 259 | 0.17 | Why? |
| Diabetic Nephropathies | 1 | 2021 | 315 | 0.16 | Why? |
| NAD | 1 | 2017 | 73 | 0.16 | Why? |
| Gait Disorders, Neurologic | 1 | 2017 | 64 | 0.16 | Why? |
| Antibody-Dependent Enhancement | 1 | 2020 | 413 | 0.16 | Why? |
| Lipoproteins, LDL | 1 | 2017 | 115 | 0.16 | Why? |
| Insulin-Like Growth Factor I | 1 | 2017 | 119 | 0.16 | Why? |
| Adiponectin | 1 | 2017 | 123 | 0.16 | Why? |
| Cardiovascular Diseases | 3 | 2019 | 11497 | 0.16 | Why? |
| Endemic Diseases | 1 | 2020 | 480 | 0.15 | Why? |
| Vaccines, Conjugate | 1 | 2018 | 328 | 0.15 | Why? |
| Lipoproteins, HDL | 1 | 2017 | 154 | 0.15 | Why? |
| Health Plan Implementation | 1 | 2020 | 571 | 0.15 | Why? |
| Nerve Tissue Proteins | 1 | 2017 | 319 | 0.15 | Why? |
| Tinnitus | 1 | 2017 | 148 | 0.14 | Why? |
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 317 | 0.14 | Why? |
| Abscess | 1 | 2017 | 234 | 0.14 | Why? |
| Glomerular Filtration Rate | 1 | 2021 | 1262 | 0.14 | Why? |
| Ethics, Medical | 1 | 2021 | 533 | 0.13 | Why? |
| Pneumonia, Pneumococcal | 1 | 2017 | 251 | 0.13 | Why? |
| Post-Exposure Prophylaxis | 1 | 2018 | 472 | 0.13 | Why? |
| Blood Glucose | 3 | 2018 | 3642 | 0.13 | Why? |
| Papillomavirus Vaccines | 1 | 2019 | 405 | 0.13 | Why? |
| Drainage | 1 | 2017 | 414 | 0.13 | Why? |
| Immunization Programs | 3 | 2021 | 2006 | 0.13 | Why? |
| Rats | 2 | 2018 | 2764 | 0.13 | Why? |
| RNA | 1 | 2020 | 1278 | 0.12 | Why? |
| Respiratory Tract Diseases | 1 | 2020 | 1061 | 0.12 | Why? |
| Vaccination Refusal | 1 | 2020 | 831 | 0.12 | Why? |
| Vaccines, Synthetic | 2 | 2021 | 3231 | 0.11 | Why? |
| Recombinant Proteins | 1 | 2020 | 3786 | 0.10 | Why? |
| Humans | 38 | 2021 | 930598 | 0.10 | Why? |
| Metabolic Syndrome | 1 | 2018 | 810 | 0.10 | Why? |
| Sex Distribution | 1 | 2017 | 2083 | 0.10 | Why? |
| Insulin | 2 | 2017 | 1316 | 0.10 | Why? |
| Adolescent | 15 | 2021 | 86841 | 0.10 | Why? |
| Pre-Exposure Prophylaxis | 1 | 2018 | 1138 | 0.10 | Why? |
| Male | 22 | 2021 | 367725 | 0.10 | Why? |
| Vaccination | 3 | 2020 | 19050 | 0.10 | Why? |
| Resource Allocation | 1 | 2021 | 1771 | 0.10 | Why? |
| Glycated Hemoglobin A | 1 | 2017 | 1316 | 0.09 | Why? |
| Risk Factors | 8 | 2019 | 71621 | 0.09 | Why? |
| Mice, Knockout | 3 | 2019 | 1815 | 0.09 | Why? |
| Female | 21 | 2021 | 380317 | 0.09 | Why? |
| Sodium | 2 | 2017 | 309 | 0.09 | Why? |
| Serotyping | 2 | 2018 | 154 | 0.09 | Why? |
| Homeless Persons | 1 | 2019 | 1171 | 0.09 | Why? |
| Thrombocytopenia | 1 | 2021 | 2093 | 0.09 | Why? |
| Age Distribution | 1 | 2017 | 3567 | 0.08 | Why? |
| Biomarkers | 3 | 2021 | 23361 | 0.08 | Why? |
| Membrane Proteins | 1 | 2017 | 1733 | 0.08 | Why? |
| Survival Analysis | 1 | 2021 | 7592 | 0.08 | Why? |
| Evidence-Based Medicine | 1 | 2020 | 3228 | 0.08 | Why? |
| Nutritional Status | 1 | 2017 | 1403 | 0.08 | Why? |
| Adult | 15 | 2021 | 244371 | 0.08 | Why? |
| Middle Aged | 13 | 2021 | 270681 | 0.08 | Why? |
| Renal Insufficiency, Chronic | 1 | 2021 | 2654 | 0.08 | Why? |
| Myocarditis | 1 | 2021 | 2731 | 0.07 | Why? |
| Animals | 7 | 2019 | 78931 | 0.07 | Why? |
| Pediatrics | 1 | 2020 | 2969 | 0.07 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.07 | Why? |
| Aged | 11 | 2021 | 215776 | 0.07 | Why? |
| Aged, 80 and over | 6 | 2021 | 88759 | 0.07 | Why? |
| Sex Factors | 2 | 2019 | 11014 | 0.07 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.07 | Why? |
| Dementia | 1 | 2018 | 1861 | 0.07 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.06 | Why? |
| Brain Ischemia | 1 | 2018 | 2813 | 0.06 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.06 | Why? |
| Safety-Based Drug Withdrawals | 1 | 2021 | 52 | 0.06 | Why? |
| Clinical Trials, Phase IV as Topic | 1 | 2020 | 75 | 0.05 | Why? |
| Drug Labeling | 1 | 2021 | 65 | 0.05 | Why? |
| Infant | 6 | 2019 | 30274 | 0.05 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.05 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.05 | Why? |
| Travel | 1 | 2018 | 7220 | 0.05 | Why? |
| Child | 8 | 2021 | 70012 | 0.05 | Why? |
| Potassium | 2 | 2017 | 325 | 0.05 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.05 | Why? |
| Young Adult | 8 | 2021 | 93724 | 0.05 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.05 | Why? |
| Thrombosis | 1 | 2021 | 7504 | 0.05 | Why? |
| Anti-Bacterial Agents | 2 | 2018 | 10083 | 0.05 | Why? |
| Homeostasis | 2 | 2018 | 582 | 0.04 | Why? |
| Albuminuria | 1 | 2019 | 164 | 0.04 | Why? |
| Corticosterone | 1 | 2017 | 18 | 0.04 | Why? |
| Genotype | 3 | 2017 | 4697 | 0.04 | Why? |
| Prevalence | 2 | 2017 | 25773 | 0.04 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.04 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.04 | Why? |
| Child, Preschool | 5 | 2019 | 36283 | 0.04 | Why? |
| Hospitals, Pediatric | 2 | 2018 | 1792 | 0.04 | Why? |
| Cohort Studies | 5 | 2018 | 36005 | 0.04 | Why? |
| Clinical Trials, Phase III as Topic | 1 | 2021 | 782 | 0.04 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.04 | Why? |
| Hospitalization | 2 | 2017 | 54280 | 0.04 | Why? |
| Receptors, Glucocorticoid | 1 | 2017 | 118 | 0.04 | Why? |
| PubMed | 1 | 2018 | 246 | 0.04 | Why? |
| Residential Facilities | 1 | 2020 | 443 | 0.04 | Why? |
| Cytokines | 1 | 2017 | 15010 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.04 | Why? |
| Polymorphism, Genetic | 2 | 2017 | 1074 | 0.03 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.03 | Why? |
| Neutropenia | 1 | 2017 | 388 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2017 | 1224 | 0.03 | Why? |
| Immunoglobulins | 1 | 2018 | 811 | 0.03 | Why? |
| Influenza, Human | 1 | 2017 | 10779 | 0.03 | Why? |
| Massachusetts | 1 | 2017 | 1279 | 0.03 | Why? |
| Emergency Service, Hospital | 1 | 2017 | 14232 | 0.03 | Why? |
| Vaccines, Inactivated | 1 | 2018 | 1562 | 0.03 | Why? |
| Papillomavirus Infections | 1 | 2019 | 861 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2017 | 25144 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.03 | Why? |
| Health Equity | 1 | 2021 | 1223 | 0.02 | Why? |
| Social Determinants of Health | 1 | 2021 | 1757 | 0.02 | Why? |
| Risk | 1 | 2021 | 5288 | 0.02 | Why? |
| Follow-Up Studies | 2 | 2017 | 17020 | 0.02 | Why? |
| Mice | 2 | 2018 | 21357 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2019 | 5542 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2020 | 3129 | 0.02 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.02 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 2984 | 0.02 | Why? |
| Emergencies | 1 | 2021 | 4095 | 0.02 | Why? |
| Antiviral Agents | 1 | 2017 | 41703 | 0.02 | Why? |
| Influenza Vaccines | 1 | 2020 | 2941 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2017 | 6543 | 0.02 | Why? |
| Health Status Disparities | 1 | 2021 | 4072 | 0.02 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2021 | 10649 | 0.01 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.01 | Why? |
| Age Factors | 1 | 2019 | 21039 | 0.01 | Why? |
| Infant, Newborn | 1 | 2018 | 23105 | 0.01 | Why? |
| Viral Load | 1 | 2017 | 15850 | 0.01 | Why? |
| Public Health | 1 | 2021 | 16359 | 0.01 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.01 | Why? |
| Comorbidity | 1 | 2017 | 34796 | 0.01 | Why? |
| Prospective Studies | 1 | 2017 | 43301 | 0.01 | Why? |
| Hydrocortisone | 1 | 2002 | 1790 | 0.01 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.01 | Why? |
Romero's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(197)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(53)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_